Gilead Sciences, Inc.: Gilead Presents Long-Term Switch Data

- Analysis of Real-World Data in People Living With HIV in the International BICSTaR Study to be Presented at EACS 2021 Also Confirm the Long-Term Efficacy and Safety Profile of Biktarvy - Gilead

Related Keywords

Uganda , South Africa , California , United States , Canada , Foster City , Israel , London , City Of , United Kingdom , Jacquie Ross , Brian Plummer , Frank Duff , Prevention Research , Gilead Sciences , Crcl About Gilead Sciences , Gilead Sciences Inc , Nasdaq , Exchange Commission , Gilead On Twitter Sciences , Gilead Public Affairs , Cure Research , Treatment Research , International Bicstar Study , Treatment Research Lenacapavir , Real World Data , People Living With , Long Term Efficacy , Safety Profile , Senior Vice President , Virology Therapeutic Area Head , Important Safety Information , Boxed Warnings , Safety Information , Drug Interactions , Antiretroviral Pregnancy Registry , Prescribing Information , About Gilead , Private Securities Litigation Reform Act , Quarterly Report , Gilead , Ciences , Presents , Song , Term , Switch , Data , Reinforcing , Biktarvy , Treatment , Option , Road , Orange , People , Diving , Ith ,